Evidence map›Paper›PMID 42776983›Full record

ArticlePloS one2026

Identification of rs28362336 as a risk SNP for generalized myasthenia gravis and its impact on HCG27 regulation.

Zihong Chen, Qingling Guo, Liting Tian, Jingnan Jin, Xia Wang, Chunyu Yu, Yichen Li, Jingjing Zhang, Yan Li, Yufan Zhao and 4 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zihong ChenDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID https://orcid.org/0009-0006-8558-072X
Qingling GuoDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Liting TianDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jingnan JinDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Xia WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Chunyu YuDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yichen LiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jingjing ZhangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yan LiDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yufan ZhaoDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jiayi ZhangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Lanxin ZhangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Lukuan QiaoDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Jianjian WangDepartment of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID https://orcid.org/0000-0001-5568-4612

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junctions. Accumulating amounts of evidence have indicated that single nucleotide polymorphisms (SNPs) and long noncoding RNAs (lncRNAs) play critical roles in the pathogenesis of MG; however, research on MG-related lncRNA SNPs remains limited. Therefore, our study focused on MG-related lncRNA SNPs to explore their association with genetic susceptibility to MG. We screened regulatory SNPs using MG GWAS data and conducted a case‒control study including 161 patients and 161 controls. After SNaPshot genotyping, LASSO regression and random forest were used to identify SNP-related risk factors. We performed eQTL analysis and ChIP-PCR to identify the functional role and underlying mechanism of rs28362336. qRT-PCR was performed to measure HCG27 expression in MG patients and to further assess HCG27 expression in generalized MG (gMG) patients. Finally, fluorescence in situ hybridization was used to determine the subcellular localization of HCG27 in CD4 + T cells, and the effects of HCG27 overexpression or knockdown were evaluated by Western blot analysis and CCK-8 assays. Significant SNPs were identified on chromosomes 1, 6, 11, 17, and 18. Although no differences in genotype or allele frequency were observed between the cases and controls overall, subtype analysis revealed that HCG27 rs9263872(TT), rs9263875(GG), and rs28362336(GG) were associated with gMG risk. The rs9263875 G allele was associated with gMG, whereas the HCG9 rs3823381 T allele was associated with ocular MG (oMG). Machine learning analysis further revealed that rs28362336 is a risk factor of MG. Bioinformatics and ChIP-PCR revealed H3K4me1, H3K27ac, and Pol II enrichment at the rs28362336 locus, suggesting enhancer activity upstream of HCG27. HCG27 expression was increased in MG patients, particularly in gMG harboring the rs28362336 GG genotype. Finally, HCG27 promoted CD4 + T cell proliferation and inhibited apoptosis. This study revealed the associations of HCG27-related SNPs with gMG and the potential regulatory role of rs28362336 in HCG27 expression. Moreover, the upregulation of HCG27 in MG patients and its proliferation-promoting effect in CD4 + T cells suggest that HCG27 may contribute to MG pathogenesis.

Indexed as

Genetic Predisposition to DiseaseMyasthenia GravisPolymorphism, Single NucleotideRNA, Long NoncodingAdultCase-Control StudiesFemaleGene FrequencyGenome-Wide Association StudyGenotypeHumansMaleMiddle AgedQuantitative Trait LociRisk FactorsRNA, Long Noncoding

Identifiers

PMID42776983
PMCPMC13600526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.